IBDEI0NM ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,10631,2)
;;=^5003049
;;^UTILITY(U,$J,358.3,10632,0)
;;=F02.80^^42^472^40
;;^UTILITY(U,$J,358.3,10632,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10632,1,3,0)
;;=3^Major Neurocog D/O d/t Poss PARKINSON'S DISEASE w/o Behav Disturb
;;^UTILITY(U,$J,358.3,10632,1,4,0)
;;=4^F02.80
;;^UTILITY(U,$J,358.3,10632,2)
;;=^5003048
;;^UTILITY(U,$J,358.3,10633,0)
;;=F02.81^^42^472^45
;;^UTILITY(U,$J,358.3,10633,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10633,1,3,0)
;;=3^Major Neurocog D/O d/t Prob PARKINSON'S DISEASE w/ Behav Disturb
;;^UTILITY(U,$J,358.3,10633,1,4,0)
;;=4^F02.81
;;^UTILITY(U,$J,358.3,10633,2)
;;=^5003049
;;^UTILITY(U,$J,358.3,10634,0)
;;=F02.80^^42^472^46
;;^UTILITY(U,$J,358.3,10634,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10634,1,3,0)
;;=3^Major Neurocog D/O d/t Prob PARKINSON'S DISEASE w/o Behav Disturb
;;^UTILITY(U,$J,358.3,10634,1,4,0)
;;=4^F02.80
;;^UTILITY(U,$J,358.3,10634,2)
;;=^5003048
;;^UTILITY(U,$J,358.3,10635,0)
;;=G31.84^^42^472^63
;;^UTILITY(U,$J,358.3,10635,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10635,1,3,0)
;;=3^Mild Neurocog D/O d/t PARKINSON'S DISEASE
;;^UTILITY(U,$J,358.3,10635,1,4,0)
;;=4^G31.84
;;^UTILITY(U,$J,358.3,10635,2)
;;=^5003813
;;^UTILITY(U,$J,358.3,10636,0)
;;=A81.9^^42^472^72
;;^UTILITY(U,$J,358.3,10636,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10636,1,3,0)
;;=3^Prion Disease
;;^UTILITY(U,$J,358.3,10636,1,4,0)
;;=4^A81.9
;;^UTILITY(U,$J,358.3,10636,2)
;;=^5000414
;;^UTILITY(U,$J,358.3,10637,0)
;;=F02.81^^42^472^33
;;^UTILITY(U,$J,358.3,10637,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10637,1,3,0)
;;=3^Major Neurocog D/O d/t PRION DISEASE w/ Behav Disturb
;;^UTILITY(U,$J,358.3,10637,1,4,0)
;;=4^F02.81
;;^UTILITY(U,$J,358.3,10637,2)
;;=^5003049
;;^UTILITY(U,$J,358.3,10638,0)
;;=F02.80^^42^472^34
;;^UTILITY(U,$J,358.3,10638,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10638,1,3,0)
;;=3^Major Neurocog D/O d/t PRION DISEASE w/o Behav Disturb
;;^UTILITY(U,$J,358.3,10638,1,4,0)
;;=4^F02.80
;;^UTILITY(U,$J,358.3,10638,2)
;;=^5003048
;;^UTILITY(U,$J,358.3,10639,0)
;;=G31.84^^42^472^64
;;^UTILITY(U,$J,358.3,10639,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10639,1,3,0)
;;=3^Mild Neurocog D/O d/t PRION DISEASE
;;^UTILITY(U,$J,358.3,10639,1,4,0)
;;=4^G31.84
;;^UTILITY(U,$J,358.3,10639,2)
;;=^5003813
;;^UTILITY(U,$J,358.3,10640,0)
;;=S06.2X9S^^42^472^75
;;^UTILITY(U,$J,358.3,10640,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10640,1,3,0)
;;=3^TRAUMATIC BRAIN INJURY,Diffuse w/ Unspec Duration of LOC,Sequela
;;^UTILITY(U,$J,358.3,10640,1,4,0)
;;=4^S06.2X9S
;;^UTILITY(U,$J,358.3,10640,2)
;;=^5020755
;;^UTILITY(U,$J,358.3,10641,0)
;;=F02.81^^42^472^51
;;^UTILITY(U,$J,358.3,10641,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10641,1,3,0)
;;=3^Major Neurocog D/O d/t TBI w/ Behav Disturb
;;^UTILITY(U,$J,358.3,10641,1,4,0)
;;=4^F02.81
;;^UTILITY(U,$J,358.3,10641,2)
;;=^5003049
;;^UTILITY(U,$J,358.3,10642,0)
;;=F02.80^^42^472^52
;;^UTILITY(U,$J,358.3,10642,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10642,1,3,0)
;;=3^Major Neurocog D/O d/t TBI w/o Behav Disturb
;;^UTILITY(U,$J,358.3,10642,1,4,0)
;;=4^F02.80
;;^UTILITY(U,$J,358.3,10642,2)
;;=^5003048
;;^UTILITY(U,$J,358.3,10643,0)
;;=G31.84^^42^472^65
;;^UTILITY(U,$J,358.3,10643,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10643,1,3,0)
;;=3^Mild Neurocog D/O d/t TBI
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0NM 3809 printed Sep 23, 2025@19:28:10 Page 2
IBDEI0NM ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,10631,2)
+2 ;;=^5003049
+3 ;;^UTILITY(U,$J,358.3,10632,0)
+4 ;;=F02.80^^42^472^40
+5 ;;^UTILITY(U,$J,358.3,10632,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,10632,1,3,0)
+8 ;;=3^Major Neurocog D/O d/t Poss PARKINSON'S DISEASE w/o Behav Disturb
+9 ;;^UTILITY(U,$J,358.3,10632,1,4,0)
+10 ;;=4^F02.80
+11 ;;^UTILITY(U,$J,358.3,10632,2)
+12 ;;=^5003048
+13 ;;^UTILITY(U,$J,358.3,10633,0)
+14 ;;=F02.81^^42^472^45
+15 ;;^UTILITY(U,$J,358.3,10633,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,10633,1,3,0)
+18 ;;=3^Major Neurocog D/O d/t Prob PARKINSON'S DISEASE w/ Behav Disturb
+19 ;;^UTILITY(U,$J,358.3,10633,1,4,0)
+20 ;;=4^F02.81
+21 ;;^UTILITY(U,$J,358.3,10633,2)
+22 ;;=^5003049
+23 ;;^UTILITY(U,$J,358.3,10634,0)
+24 ;;=F02.80^^42^472^46
+25 ;;^UTILITY(U,$J,358.3,10634,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,10634,1,3,0)
+28 ;;=3^Major Neurocog D/O d/t Prob PARKINSON'S DISEASE w/o Behav Disturb
+29 ;;^UTILITY(U,$J,358.3,10634,1,4,0)
+30 ;;=4^F02.80
+31 ;;^UTILITY(U,$J,358.3,10634,2)
+32 ;;=^5003048
+33 ;;^UTILITY(U,$J,358.3,10635,0)
+34 ;;=G31.84^^42^472^63
+35 ;;^UTILITY(U,$J,358.3,10635,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,10635,1,3,0)
+38 ;;=3^Mild Neurocog D/O d/t PARKINSON'S DISEASE
+39 ;;^UTILITY(U,$J,358.3,10635,1,4,0)
+40 ;;=4^G31.84
+41 ;;^UTILITY(U,$J,358.3,10635,2)
+42 ;;=^5003813
+43 ;;^UTILITY(U,$J,358.3,10636,0)
+44 ;;=A81.9^^42^472^72
+45 ;;^UTILITY(U,$J,358.3,10636,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,10636,1,3,0)
+48 ;;=3^Prion Disease
+49 ;;^UTILITY(U,$J,358.3,10636,1,4,0)
+50 ;;=4^A81.9
+51 ;;^UTILITY(U,$J,358.3,10636,2)
+52 ;;=^5000414
+53 ;;^UTILITY(U,$J,358.3,10637,0)
+54 ;;=F02.81^^42^472^33
+55 ;;^UTILITY(U,$J,358.3,10637,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,10637,1,3,0)
+58 ;;=3^Major Neurocog D/O d/t PRION DISEASE w/ Behav Disturb
+59 ;;^UTILITY(U,$J,358.3,10637,1,4,0)
+60 ;;=4^F02.81
+61 ;;^UTILITY(U,$J,358.3,10637,2)
+62 ;;=^5003049
+63 ;;^UTILITY(U,$J,358.3,10638,0)
+64 ;;=F02.80^^42^472^34
+65 ;;^UTILITY(U,$J,358.3,10638,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,10638,1,3,0)
+68 ;;=3^Major Neurocog D/O d/t PRION DISEASE w/o Behav Disturb
+69 ;;^UTILITY(U,$J,358.3,10638,1,4,0)
+70 ;;=4^F02.80
+71 ;;^UTILITY(U,$J,358.3,10638,2)
+72 ;;=^5003048
+73 ;;^UTILITY(U,$J,358.3,10639,0)
+74 ;;=G31.84^^42^472^64
+75 ;;^UTILITY(U,$J,358.3,10639,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,10639,1,3,0)
+78 ;;=3^Mild Neurocog D/O d/t PRION DISEASE
+79 ;;^UTILITY(U,$J,358.3,10639,1,4,0)
+80 ;;=4^G31.84
+81 ;;^UTILITY(U,$J,358.3,10639,2)
+82 ;;=^5003813
+83 ;;^UTILITY(U,$J,358.3,10640,0)
+84 ;;=S06.2X9S^^42^472^75
+85 ;;^UTILITY(U,$J,358.3,10640,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,10640,1,3,0)
+88 ;;=3^TRAUMATIC BRAIN INJURY,Diffuse w/ Unspec Duration of LOC,Sequela
+89 ;;^UTILITY(U,$J,358.3,10640,1,4,0)
+90 ;;=4^S06.2X9S
+91 ;;^UTILITY(U,$J,358.3,10640,2)
+92 ;;=^5020755
+93 ;;^UTILITY(U,$J,358.3,10641,0)
+94 ;;=F02.81^^42^472^51
+95 ;;^UTILITY(U,$J,358.3,10641,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,10641,1,3,0)
+98 ;;=3^Major Neurocog D/O d/t TBI w/ Behav Disturb
+99 ;;^UTILITY(U,$J,358.3,10641,1,4,0)
+100 ;;=4^F02.81
+101 ;;^UTILITY(U,$J,358.3,10641,2)
+102 ;;=^5003049
+103 ;;^UTILITY(U,$J,358.3,10642,0)
+104 ;;=F02.80^^42^472^52
+105 ;;^UTILITY(U,$J,358.3,10642,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,10642,1,3,0)
+108 ;;=3^Major Neurocog D/O d/t TBI w/o Behav Disturb
+109 ;;^UTILITY(U,$J,358.3,10642,1,4,0)
+110 ;;=4^F02.80
+111 ;;^UTILITY(U,$J,358.3,10642,2)
+112 ;;=^5003048
+113 ;;^UTILITY(U,$J,358.3,10643,0)
+114 ;;=G31.84^^42^472^65
+115 ;;^UTILITY(U,$J,358.3,10643,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,10643,1,3,0)
+118 ;;=3^Mild Neurocog D/O d/t TBI
